<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>海滨重症</title>
  
  <subtitle>SeasideCCM</subtitle>
  <link href="https://humorlife.github.io/atom.xml" rel="self"/>
  
  <link href="https://humorlife.github.io/"/>
  <updated>2021-02-21T11:35:18.650Z</updated>
  <id>https://humorlife.github.io/</id>
  
  <author>
    <name>SeasideCCM</name>
    
  </author>
  
  <generator uri="https://hexo.io/">Hexo</generator>
  
  <entry>
    <title>AI在医学影像应用的5个原则</title>
    <link href="https://humorlife.github.io/2021/02/21/AI%E5%9C%A8%E5%8C%BB%E5%AD%A6%E5%BD%B1%E5%83%8F%E5%BA%94%E7%94%A8%E7%9A%845%E4%B8%AA%E5%8E%9F%E5%88%99/"/>
    <id>https://humorlife.github.io/2021/02/21/AI%E5%9C%A8%E5%8C%BB%E5%AD%A6%E5%BD%B1%E5%83%8F%E5%BA%94%E7%94%A8%E7%9A%845%E4%B8%AA%E5%8E%9F%E5%88%99/</id>
    <published>2021-02-21T11:34:50.000Z</published>
    <updated>2021-02-21T11:35:18.650Z</updated>
    
    <content type="html"><![CDATA[<h1 id="Five-principles-for-the-intelligent-use-of-AI-in-medical-imaging"><a href="#Five-principles-for-the-intelligent-use-of-AI-in-medical-imaging" class="headerlink" title="Five principles for the intelligent use of AI in medical imaging"></a>Five principles for the intelligent use of AI in medical imaging</h1><ul><li><a href="javascript:;">Errol Colak</a>             <a href="http://61.175.198.136:8083/rwt/150/http/N73GG4LEF3YYE3D/0000-0002-3771-7975">ORCID: orcid.org/0000-0002-3771-7975</a><a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff1">1</a>,<a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff2">2</a>, </li><li><a href="javascript:;">Robert Moreland</a>             <a href="http://61.175.198.136:8083/rwt/150/http/N73GG4LEF3YYE3D/0000-0001-5456-1637">ORCID: orcid.org/0000-0001-5456-1637</a><a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff3">3</a>,<a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff4">4</a> &amp; </li><li><a href="javascript:;">Marzyeh Ghassemi</a>             <a href="http://61.175.198.136:8083/rwt/150/http/N73GG4LEF3YYE3D/0000-0001-6349-7251">ORCID: orcid.org/0000-0001-6349-7251</a><a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff5">5</a>,<a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#Aff6">6</a> </li></ul><p><a href="http://61.175.198.136:8083/journal/134"><em>Intensive Care Medicine</em></a>                             <strong>volume 47</strong>, pages154–156(2021)<a href="http://61.175.198.136:8083/rwt/150/https/NSVX643PPNZHE4LPM7TYELUDN7XB/article/10.1007/s00134-020-06316-8#citeas">Cite this article</a>                         </p><ul><li>1901 Accesses</li><li>21 Altmetric</li><li><a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8/metrics">Metrics details</a></li></ul><h2 id="Clinical-scenario"><a href="#Clinical-scenario" class="headerlink" title="Clinical scenario"></a>Clinical scenario</h2><p>You are a critical care physician at a medium-sized urban hospital. A local start-up is promoting software that claims to automatically interpret chest X-rays. Having read many articles about artificial intelligence, you are intrigued by the idea of using it. However, you have never had to decide if, when, and how to deploy these technologies in clinical practice.</p><h2 id="Background"><a href="#Background" class="headerlink" title="Background"></a>Background</h2><p>Artificial intelligence (AI) promises to transform healthcare by improving clinical decision-making, reducing errors, and automating tasks [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR1">1</a>]. Recent advances in machine learning (ML), a branch of AI, have demonstrated expert-level task performance including medical image analysis [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR2">2</a>]. With an increasing number of medical imaging ML systems receiving regulatory approval, critical care physicians will have an additional set of tools at their disposal. However, the deployment of these systems into clinical environments can be fraught with pitfalls. This article introduces 5 key principles that should be remembered as the adoption of ML systems becomes more widespread.</p><h3 id="Knowledge-base-ensure-you-have-enough-understanding-of-machine-learning-to-separate-fact-from-fiction-in-vendor-claims"><a href="#Knowledge-base-ensure-you-have-enough-understanding-of-machine-learning-to-separate-fact-from-fiction-in-vendor-claims" class="headerlink" title="Knowledge base: ensure you have enough understanding of machine learning to separate fact from fiction in vendor claims"></a>Knowledge base: ensure you have enough understanding of machine learning to separate fact from fiction in vendor claims</h3><p>If physicians are to be integral to the development, adoption, and oversight of ML models, it is paramount for them to develop basic competency in ML. Physicians should become familiar with dataset preparation, model architecture selection, and how statistical methods are applied during model evaluation. Knowledge and skills in ML would empower physicians to understand the potential capabilities and limitations of ML, critically appraise and validate models, and address patient concerns. A deeper understanding of how ML models are created and evaluated may help to determine how model outputs can be best integrated into clinical decision-making. Readers are encouraged to explore the many online educational resources, many free of charge, that are available for self-directed and class-based learning (Supplemental Material).</p><h3 id="Metrics-ensure-that-the-evaluation-metrics-provided-by-the-vendor-are-meaningful-in-clinical-practice-and-not-limited-to-accuracy"><a href="#Metrics-ensure-that-the-evaluation-metrics-provided-by-the-vendor-are-meaningful-in-clinical-practice-and-not-limited-to-accuracy" class="headerlink" title="Metrics: ensure that the evaluation metrics provided by the vendor are meaningful in clinical practice and not limited to accuracy"></a>Metrics: ensure that the evaluation metrics provided by the vendor are meaningful in clinical practice and not limited to accuracy</h3><p>Model performance is often reported as an accuracy measure or confusion matrix. This is potentially problematic as models may demonstrate reduced accuracy when operating under real-world circumstances [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR3">3</a>]. Furthermore, these metrics fail to consider prevalence, the impact of incorrect recommendations, and may in fact convey a false sense of safety. Determining a model’s clinical benefit, robustness, direct and indirect costs, calibration, safety profile, interpretability, and user acceptance are much more meaningful forms of evaluation and are unfortunately often not available [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR4">4</a>]. Rather than focusing on the area under the curve, a commonly used metric in the ML literature, the focus needs to be on rigorous clinical validation. The validation process for a novel ML model should be no less rigorous and thorough than that of a new drug or diagnostic test to ensure efficacy, reliability, acceptability, and safety [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR5">5</a>].</p><h3 id="Bias-ensure-the-data-used-for-model-development-by-the-vendor-reflects-the-case-mix-of-your-ICU-and-that-the-model-has-been-validated-using-external-datasets"><a href="#Bias-ensure-the-data-used-for-model-development-by-the-vendor-reflects-the-case-mix-of-your-ICU-and-that-the-model-has-been-validated-using-external-datasets" class="headerlink" title="Bias: ensure the data used for model development by the vendor reflects the case mix of your ICU and that the model has been validated using external datasets."></a>Bias: ensure the data used for model development by the vendor reflects the case mix of your ICU and that the model has been validated using external datasets.</h3><p>At their heart ML models are pattern recognition systems and can perform poorly outside the scope of the data used to train them [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR6">6</a>]. They are highly dependent on the characteristics of this training data and vulnerable to any underlying selection biases. Specific patient populations and types of pathology may be under-represented during training but commonly encountered in your practice. Selection bias can reflect the patient population (e.g., age, gender, race), range of pathology (e.g., type and severity), and medical images (e.g., specific equipment, imaging protocol, patient positioning) used during training [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR7">7</a>]. When evaluating an ML system, it is critical to understand the composition of the imaging studies used for training and whether it approximates those at your institution. Models trained on larger and more generalized datasets reduce the risks from bias but cannot entirely eliminate it.</p><h3 id="Model-fragility-ensure-the-vendor-provides-the-parameters-within-which-their-model-should-operate-safely"><a href="#Model-fragility-ensure-the-vendor-provides-the-parameters-within-which-their-model-should-operate-safely" class="headerlink" title="Model fragility: ensure the vendor provides the parameters within which their model should operate safely."></a>Model fragility: ensure the vendor provides the parameters within which their model should operate safely.</h3><p>The behavior of an ML system outside the scope of training data can be unpredictable and potentially unsafe [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR8">8</a>]. For example, ML models may fail to detect obvious pathology if the imaging study presented is dissimilar to training data [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR9">9</a>]. More disturbing is that ML models may fail to recognize that they are operating beyond their “comfort zone” and produce incorrect outputs with high confidence [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR10">10</a>]. Also, ML systems are often trained to distill complex imaging data down to simple binary results: is the pathology present or not? This loss of granularity can result in cases close to the decision boundary being marked as normal even when clinically relevant findings may be present. When considering the implementation of an ML system, it is important to know the parameters within which the model should operate safely, if the model provides a measure of prediction confidence, and how the model will respond to the incomplete or poor-quality imaging studies that are often encountered in the real world.</p><h3 id="Error-prone-behavior-ensure-the-clinical-team-does-not-develop-overdependence-on-the-ML-technology-and-loses-sight-of-its-fallibilities"><a href="#Error-prone-behavior-ensure-the-clinical-team-does-not-develop-overdependence-on-the-ML-technology-and-loses-sight-of-its-fallibilities" class="headerlink" title="Error-prone behavior: ensure the clinical team does not develop overdependence on the ML technology and loses sight of its fallibilities"></a>Error-prone behavior: ensure the clinical team does not develop overdependence on the ML technology and loses sight of its fallibilities</h3><p>Computer aids and automation are employed to improve efficiency and reduce error. However, they may actually lead to new and different types of errors [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR11">11</a>]. Individuals may hold beliefs about the superiority of computer systems over human experts [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR12">12</a>] and a consistently reliable system may even appear infallible. Blind trust in computer aids may impair an individual’s ability to recognize incorrect computer advice which may ultimately result in decision errors [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR11">11</a>]. Furthermore, there is a risk of over-reliance on computer aids particularly in a clinical setting when many concurrent tasks compete for an individual’s time and attention [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR13">13</a>]. Critical care physicians must be aware that ML models are imperfect and can be used in biased ways; so, human judgment will be necessary in determining how much weight should be given to them in the clinical decision-making process.</p><h2 id="Revisiting-the-clinical-scenario"><a href="#Revisiting-the-clinical-scenario" class="headerlink" title="Revisiting the clinical scenario"></a>Revisiting the clinical scenario</h2><p>Having improved your understanding of AI systems, you realize the usefulness of the proposed system may be overstated. Similar to many current commercial systems targeting medical imaging, the start-up is marketing the product for widespread use but has not validated it on external data or in a full clinical setting [<a href="http://61.175.198.136:8083/article/10.1007/s00134-020-06316-8#ref-CR14">14</a>]. Worse, its small training set consists mostly of PA radiographs of non-ICU patients which are notably different from your typical patients. Keenly aware that the value of the system is solely how it behaves in your institution, you insist on more thorough evaluation of the product with local imaging cases prior to further consideration.</p><h3 id="Key-points-for-the-intelligent-use-of-AI-in-medical-imaging"><a href="#Key-points-for-the-intelligent-use-of-AI-in-medical-imaging" class="headerlink" title="Key points for the intelligent use of AI in medical imaging"></a>Key points for the intelligent use of AI in medical imaging</h3><table><thead><tr><th>To effectively evaluate a machine learning (ML) system, you should understand how they are created and the common methods used to assess them.</th></tr></thead><tbody><tr><td>Proper evaluation of an ML system requires you to consider more than the tool’s accuracy or ROC curve.</td></tr><tr><td>ML systems can be biased in a variety of ways and one that works well in one clinical environment may perform very poorly in another.</td></tr><tr><td>It is common for ML systems to behave unpredictably and potentially dangerously outside the scope of their training data.</td></tr><tr><td>Using an ML system can introduce new types of errors into the clinical decision process.</td></tr></tbody></table><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kity@2.0.4/dist/kity.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kityminder-core@1.4.50/dist/kityminder.core.min.js"></script><script defer="true" type="text/javascript" src="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.js"></script><link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.css">]]></content>
    
    
      
      
    <summary type="html">&lt;h1 id=&quot;Five-principles-for-the-intelligent-use-of-AI-in-medical-imaging&quot;&gt;&lt;a href=&quot;#Five-principles-for-the-intelligent-use-of-AI-in-medical</summary>
      
    
    
    
    
  </entry>
  
  <entry>
    <title>可透过血脑屏障的抗菌药物</title>
    <link href="https://humorlife.github.io/2021/02/21/%E5%8F%AF%E9%80%8F%E8%BF%87%E8%A1%80%E8%84%91%E5%B1%8F%E9%9A%9C%E7%9A%84%E6%8A%97%E8%8F%8C%E8%8D%AF%E7%89%A9/"/>
    <id>https://humorlife.github.io/2021/02/21/%E5%8F%AF%E9%80%8F%E8%BF%87%E8%A1%80%E8%84%91%E5%B1%8F%E9%9A%9C%E7%9A%84%E6%8A%97%E8%8F%8C%E8%8D%AF%E7%89%A9/</id>
    <published>2021-02-21T01:25:06.000Z</published>
    <updated>2021-02-21T02:13:16.847Z</updated>
    
    <content type="html"><![CDATA[<h1 id="可透过血脑屏障的抗菌药物"><a href="#可透过血脑屏障的抗菌药物" class="headerlink" title="可透过血脑屏障的抗菌药物"></a>可透过血脑屏障的抗菌药物</h1><h2 id="较易透过血脑屏障"><a href="#较易透过血脑屏障" class="headerlink" title="较易透过血脑屏障"></a>较易透过血脑屏障</h2><p>哌拉西林、阿莫西林、头孢曲松、甲硝唑、利巴韦林、阿昔洛韦、更昔洛韦、异烟肼、利福平、比嗪酰胺、利福喷汀。</p><h2 id="能透过炎症血脑屏障"><a href="#能透过炎症血脑屏障" class="headerlink" title="能透过炎症血脑屏障"></a>能透过炎症血脑屏障</h2><p>青霉素、氨苄西林、氨苄西林/舒巴坦、头孢呋辛、头孢噻肟、头孢他啶、头孢哌酮、头孢吡肟、美罗培南、阿米卡星、克林霉素、万古霉素、去甲万古霉素、利福平</p><h2 id="难以透过血脑屏障"><a href="#难以透过血脑屏障" class="headerlink" title="难以透过血脑屏障"></a>难以透过血脑屏障</h2><p>头孢克洛、头孢拉定、头孢唑林、林可霉素、红霉素、亚胺培南/西司他汀</p><h2 id="表格-脑脊液浓度"><a href="#表格-脑脊液浓度" class="headerlink" title="表格 脑脊液浓度"></a>表格 脑脊液浓度</h2><table><thead><tr><th>抗菌/抗病毒药物</th><th>无炎症CFS浓度</th><th>炎症时CFS浓度</th><th></th></tr></thead><tbody><tr><td>青霉素钠</td><td>1%-3%</td><td>5%-30%</td><td></td></tr><tr><td>氨苄西林</td><td></td><td>2.9ug/ml</td><td></td></tr><tr><td>舒巴坦-氨苄西林</td><td></td><td>√</td><td></td></tr><tr><td>哌拉西林</td><td>0.36-3.65倍血清</td><td></td><td>动物(6.7±3.9)%</td></tr><tr><td>他唑巴坦</td><td>36.3±31.9%</td><td></td><td>比例高增加哌拉西林的穿透率</td></tr><tr><td>头孢呋辛</td><td>√6.4%-10%</td><td>√</td><td></td></tr><tr><td>头孢噻肟钠</td><td></td><td>√</td><td></td></tr><tr><td>头孢曲松钠</td><td>2mg/ml （5%-15%）</td><td>2mg/ml</td><td></td></tr><tr><td>头孢吡肟</td><td>10%-15%</td><td>√</td><td></td></tr><tr><td>拉氧头孢</td><td>11%-50%</td><td>动物1.4%升高到23%</td><td></td></tr><tr><td>美罗培南</td><td>√1.8%-8.9%</td><td>√增加</td><td></td></tr><tr><td>亚胺培南/西司他汀</td><td>7.3%</td><td>增加2-3倍</td><td>抽搐33%</td></tr><tr><td>氨曲南</td><td>√</td><td>2-4天为14.2%-18.4%；11-20天为5.3%-22.9%</td><td>不用于鲍曼不动</td></tr><tr><td>阿米卡星</td><td></td><td>50%</td><td></td></tr><tr><td>克林霉素</td><td></td><td>√可渗入脑脓肿脓液中</td><td></td></tr><tr><td>万古霉素</td><td>（18±5）%</td><td>√（48±22）%</td><td>糖皮质激素使得浓度降低</td></tr><tr><td>去甲万古霉素</td><td></td><td>√</td><td></td></tr><tr><td>阿昔洛韦</td><td></td><td>50%</td><td></td></tr><tr><td>更昔洛韦</td><td></td><td>24%-70%</td><td></td></tr><tr><td>利巴韦林</td><td></td><td>67%</td><td></td></tr><tr><td>异烟肼</td><td>√</td><td>√</td><td></td></tr><tr><td>利福平</td><td>√13%-42%</td><td>√增加</td><td>基因突变而耐药</td></tr><tr><td>比嗪酰胺</td><td>√</td><td>√</td><td></td></tr><tr><td>利福喷汀</td><td>√</td><td>√</td><td></td></tr><tr><td>甲硝唑</td><td>43%</td><td>脓液高于血液</td><td></td></tr><tr><td>氯霉素</td><td>50%</td><td></td><td>脂溶性</td></tr><tr><td>甲氧苄啶</td><td>18%</td><td></td><td>磺胺类进入较快</td></tr><tr><td>磺胺甲噁唑</td><td>12%</td><td></td><td></td></tr><tr><td>环丙沙星</td><td>21.3%-31.5%</td><td></td><td>喹诺酮类CNS不良反应0.7%-4.9%，0.5%较严重</td></tr><tr><td>左氧氟沙星</td><td>47%</td><td></td><td></td></tr></tbody></table><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kity@2.0.4/dist/kity.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kityminder-core@1.4.50/dist/kityminder.core.min.js"></script><script defer="true" type="text/javascript" src="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.js"></script><link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.css">]]></content>
    
    
      
      
    <summary type="html">&lt;h1 id=&quot;可透过血脑屏障的抗菌药物&quot;&gt;&lt;a href=&quot;#可透过血脑屏障的抗菌药物&quot; class=&quot;headerlink&quot; title=&quot;可透过血脑屏障的抗菌药物&quot;&gt;&lt;/a&gt;可透过血脑屏障的抗菌药物&lt;/h1&gt;&lt;h2 id=&quot;较易透过血脑屏障&quot;&gt;&lt;a href=&quot;#较易透过血</summary>
      
    
    
    
    
  </entry>
  
  <entry>
    <title>复苏与血流</title>
    <link href="https://humorlife.github.io/2021/02/20/%E5%A4%8D%E8%8B%8F%E4%B8%8E%E8%A1%80%E6%B5%81/"/>
    <id>https://humorlife.github.io/2021/02/20/%E5%A4%8D%E8%8B%8F%E4%B8%8E%E8%A1%80%E6%B5%81/</id>
    <published>2021-02-20T04:13:17.000Z</published>
    <updated>2021-02-20T10:37:22.000Z</updated>
    
    <content type="html"><![CDATA[<h1 id="血流与复苏"><a href="#血流与复苏" class="headerlink" title="血流与复苏"></a>血流与复苏</h1><h2 id="从血流视角出发看心肺复苏的心脏按压"><a href="#从血流视角出发看心肺复苏的心脏按压" class="headerlink" title="从血流视角出发看心肺复苏的心脏按压"></a>从血流视角出发看心肺复苏的心脏按压</h2><p>心跳骤停时心脏按压提供心输出量，目标是满足重要生命器官的最低血流需要。</p><p>自主心跳循环（ROSC）恢复后，MAP达不到65 mmHg 的情况很常见，即使使用血管活性药物仍有相当一部分达不到目标。</p><p>血压不达标，血流就不达标。压力差是液体流动的驱动力。</p><p>这时继续心肺复苏持续心脏按压，血压往往比停止按压要高，特别是从有创监测看非常明显，血压提升意味着相同阻力情况下血流很可能是增加的，这就给我们进一步解决心输出量不足的原因争取了时间。</p><p>心脏按压对患者造成的伤害最常见的是肋骨骨折。心肺复苏指南为了鼓励人们开始心肺复苏，提到对正常人进行心脏按压造成的伤害不大。</p><p>麻醉领域的研究表明术中抢救患者在心跳停止前就开始心肺复苏效果更好。</p><p><strong>总之，围心肺复苏期间只要血压不达标就不要停止心脏按压有可能会让一部分患者获救。</strong></p><h2 id="心跳骤停的可逆病因"><a href="#心跳骤停的可逆病因" class="headerlink" title="心跳骤停的可逆病因"></a>心跳骤停的可逆病因</h2><p>5H5T 记忆口诀</p><p>体温容量钾氢氧，</p><p>心肺栓塞填毒气。</p><p>使用白话可能更好记忆—-</p><p>体温计的容量很大能加很多氢气和氧气，</p><p>心脏和肺都有栓塞还使劲往里添加毒气，试问这些问题不解决哪儿还能活啊。</p><table><thead><tr><th align="left">5H</th><th align="left">5H中文</th></tr></thead><tbody><tr><td align="left">Hypovolemia</td><td align="left">低血容量</td></tr><tr><td align="left">Hypoxia</td><td align="left">缺氧</td></tr><tr><td align="left">Hydrogen ion (acidosis)</td><td align="left">氢离子（酸中毒）</td></tr><tr><td align="left">Hypo-/hyperkalemia</td><td align="left">低钾/高钾</td></tr><tr><td align="left">Hypothermia</td><td align="left">低体温</td></tr></tbody></table><table><thead><tr><th align="left">5T</th><th>5T中文</th></tr></thead><tbody><tr><td align="left">Tension pneumothorax</td><td>张力性气胸</td></tr><tr><td align="left">Tamponade, cardiac</td><td>心包填塞</td></tr><tr><td align="left">Toxins</td><td>中毒</td></tr><tr><td align="left">hrombosis, pulmonary</td><td>肺血栓栓塞症</td></tr><tr><td align="left">Thrombosis, coronary</td><td>心脏冠脉栓塞</td></tr></tbody></table><p><img src="/images/cpr.png" alt="CPR质量"></p><h2 id="肺血栓栓塞心肺复苏中溶栓的成功经验"><a href="#肺血栓栓塞心肺复苏中溶栓的成功经验" class="headerlink" title="肺血栓栓塞心肺复苏中溶栓的成功经验"></a>肺血栓栓塞心肺复苏中溶栓的成功经验</h2><h3 id="确保按压质量"><a href="#确保按压质量" class="headerlink" title="确保按压质量"></a>确保按压质量</h3><p>2020年12月30日，再过一天就是2021年，北戴河医院重症医学科收治了一名心肌梗死呼吸心跳骤停的男性尘肺患者，入院前经历了6次电除颤，心肺复苏时间长达20分钟。</p><p>2020年1月3日夜间患者再次心跳骤停。</p><p>医护实施心肺复苏，持续心脏按压。</p><p>通过PICCO（Pulse-indicated continuous cardiac output，脉搏指示连续心排出量监测）上的血压监测确保心脏按压的质量，要求平均动脉压（MAP）大于65 mmHg。按压中MAP可以达到 65 mmHg 以上，心跳恢复后，血压维持不住，心脏指数（CI）掉到2以下，收缩压（SBP）快速落到40mmHg以下。</p><p>马上把关键点放在血流上，首先是减少按压中断，并且盯着PICCO的数值，让MAP大于65，可以见到CI最高可以达到5.5左右。</p><h3 id="“5T”之肺栓塞"><a href="#“5T”之肺栓塞" class="headerlink" title="“5T”之肺栓塞"></a>“5T”之肺栓塞</h3><p>是什么原因？能排除肺血栓栓塞吗？</p><p>床旁超声发现右室扩大，右颈内静脉（留有中心静脉导管）、左腘静脉有血栓。</p><p>基本断定是肺栓塞，眼下可能就只有溶栓一条路。</p><p>错了怎么办？脑出血怎么办？何况昨天肺出血才刚刚停止。</p><p>根本没有时间面面俱到了，患者生还的机会随着复苏时间延长将越来越渺茫。</p><p>家属决定冒险一试，同意溶栓，这是最后一丝希望。</p><p>溶栓成功，循环逐渐稳定，当然血管活性药物逐渐减量，但不能停，患者毫无反应，瞳孔大到边。</p><p>所有努力最可能的结果仍然是失败。</p><h3 id="感染放过谁？"><a href="#感染放过谁？" class="headerlink" title="感染放过谁？"></a>感染放过谁？</h3><p>感染起来了，氧合越来越差，循环也不行了。</p><p>调整抗感染方案，纤维支气管镜吸痰，护理高要求。</p><p>1月6日下午，氧合越来越低，再次心跳骤停，又一次成功的心肺复苏。</p><p>尿少，酸中毒，需要积极解决，开始床旁血液净化治疗。</p><p>医生护士家属都在尽力做，但哪儿还有希望啊！似乎撤掉生命支持措施的那一刻随时都会到来。</p><h3 id="起死回生"><a href="#起死回生" class="headerlink" title="起死回生"></a>起死回生</h3><p>渐渐地，感染在好转，肺功能在好转，循环在好转。</p><p>不放弃，不抛弃，继续抢救。</p><p>1月11日，瞳孔有反应了，喊他睁眼了。</p><p>这是患者死过3回，昏迷12天后最令人激动和惊讶的表现了。</p><p>1月19日患者完全清醒。</p><p>后续治疗同样不简单：精心护理患者，调整镇静镇痛，撤呼吸机，拔气管插管深静脉导管，停CRRT转间断透析。</p><p>待到转普通病房时，重症医护由衷感叹：有命才有家，xxx好样的。</p><p><strong>健康所系，性命相托，我们不辱使命。</strong></p><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kity@2.0.4/dist/kity.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kityminder-core@1.4.50/dist/kityminder.core.min.js"></script><script defer="true" type="text/javascript" src="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.js"></script><link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.css">]]></content>
    
    
      
      
    <summary type="html">&lt;h1 id=&quot;血流与复苏&quot;&gt;&lt;a href=&quot;#血流与复苏&quot; class=&quot;headerlink&quot; title=&quot;血流与复苏&quot;&gt;&lt;/a&gt;血流与复苏&lt;/h1&gt;&lt;h2 id=&quot;从血流视角出发看心肺复苏的心脏按压&quot;&gt;&lt;a href=&quot;#从血流视角出发看心肺复苏的心脏按压&quot; class</summary>
      
    
    
    
    
  </entry>
  
  <entry>
    <title>碳青霉烯耐药肺炎克雷伯菌</title>
    <link href="https://humorlife.github.io/2021/02/18/%E7%A2%B3%E9%9D%92%E9%9C%89%E7%83%AF%E8%80%90%E8%8D%AF%E8%82%BA%E7%82%8E%E5%85%8B%E9%9B%B7%E4%BC%AF%E8%8F%8C/"/>
    <id>https://humorlife.github.io/2021/02/18/%E7%A2%B3%E9%9D%92%E9%9C%89%E7%83%AF%E8%80%90%E8%8D%AF%E8%82%BA%E7%82%8E%E5%85%8B%E9%9B%B7%E4%BC%AF%E8%8F%8C/</id>
    <published>2021-02-18T11:10:35.000Z</published>
    <updated>2021-02-18T11:13:58.000Z</updated>
    
    <content type="html"><![CDATA[<h2 id="耐药肺炎克雷伯菌（包括碳青霉烯耐药）"><a href="#耐药肺炎克雷伯菌（包括碳青霉烯耐药）" class="headerlink" title="耐药肺炎克雷伯菌（包括碳青霉烯耐药）"></a>耐药肺炎克雷伯菌（包括碳青霉烯耐药）</h2><h2 id="CRKP耐药机制"><a href="#CRKP耐药机制" class="headerlink" title="CRKP耐药机制"></a>CRKP耐药机制</h2><p>========<br>CRKP耐药主要是因为该菌株产碳青霉烯酶。<br>高效水解青霉素、头孢菌素、氨曲南和碳青霉烯类抗生素，其主要包括肺炎克雷伯杆菌碳青霉烯酶(Klebsiella pneumoniaecarbapenemase，KPC)、新德里金属蛋白酶(new Delhi metallo-β-lactamase，NDM)、VIM、苯唑西林酶-48(Oxacillinase-48，OXA-48)等。其中产KPC为CRKP耐药的主要原因。</p><h2 id="CRKP抗感染"><a href="#CRKP抗感染" class="headerlink" title="CRKP抗感染"></a>CRKP抗感染</h2><p>=======</p><ol><li>多黏菌素B与美罗培南或替加环素联合。</li><li>替加环素的二联、三联(包括与美罗培南的联合)</li><li>替加环素联合氨基糖苷类、环丙沙星治疗</li><li>含阿维巴坦β内酰胺酶复合制剂（头孢他啶-阿维巴坦）。</li><li>磷霉素+替加环素</li></ol><p>我国产新德里金属酶NDM基因型细菌高发，头孢他啶/阿维巴坦不能覆盖，临床治疗需要注意。</p><h2 id="CRKP抗生素治疗结局"><a href="#CRKP抗生素治疗结局" class="headerlink" title="CRKP抗生素治疗结局"></a>CRKP抗生素治疗结局</h2><p>===========<br>54个研究，3195例CRKP感染患者<br>1.病死率37.2%<br>2.临床有效69%<br>3.微生物学有效63.7%<br>4.单药治疗死亡率高于联合治疗（临床疗效和微生物学疗效无统计学差异）<br>5.两药联合与三药联合没有差异(病死率、临床疗效和微生物学疗效无统计学差异）</p><p>Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020 Jan;55(1):105833. doi: 10.1016/j.ijantimicag.2019.10.014. Epub 2019 Nov 12. PMID: 31730892.</p><p>10向研究481例CRKP感染患者。<br>1.多粘菌素单药治疗病死率高于多粘菌素联合治疗(BSI和VAP）。<br>2.亚组分析，多粘菌素单药治疗病死率高于多粘菌素与替加环素或碳青霉烯的联合治疗，但氨基糖甙类除外。<br>3.多粘菌素三药联合有明显生存获益。</p><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kity@2.0.4/dist/kity.min.js"></script><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/kityminder-core@1.4.50/dist/kityminder.core.min.js"></script><script defer="true" type="text/javascript" src="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.js"></script><link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/hexo-simple-mindmap@0.2.0/dist/mindmap.min.css">]]></content>
    
    
      
      
    <summary type="html">&lt;h2 id=&quot;耐药肺炎克雷伯菌（包括碳青霉烯耐药）&quot;&gt;&lt;a href=&quot;#耐药肺炎克雷伯菌（包括碳青霉烯耐药）&quot; class=&quot;headerlink&quot; title=&quot;耐药肺炎克雷伯菌（包括碳青霉烯耐药）&quot;&gt;&lt;/a&gt;耐药肺炎克雷伯菌（包括碳青霉烯耐药）&lt;/h2&gt;&lt;h2 id=&quot;C</summary>
      
    
    
    
    
  </entry>
  
</feed>
